Skip to content

Research use only. Not for human or veterinary use. We don’t sell products. Read more

GLP-1 & metabolic

Survodutide Price Comparison

Dual glucagon and GLP-1 receptor agonist in clinical development.

Also referred to as: BI 456906 · Dual GLP-1/Glucagon Receptor Agonist

UK supplier comparison

Use the filters to pick a size and presentation (vial, pen or serum) and compare like for like, or view every size on a £ per mg basis. Delivery is shown separately because it varies by supplier and order size. Offers whose outbound link failed our last check stay listed but rank below working links.

No live listings for Survodutide yet

Suppliers are being onboarded. This comparison will populate as listings go live. Everything below — the research profile, molecular facts and guides — is available now.

For in-vitro laboratory research only

Survodutide is listed here as a research material. It is not for human or veterinary consumption, and nothing on this page is medical advice or dosing guidance. PeptideCompare is paid by flat supplier fees — never by sales commission or referral — so a price ranks by its number, not by who pays. We do not sell, test or verify any product, and quality or CoA labels are suppliers’ own claims. Always check the final price, documentation and legality with the supplier yourself.

Research profile

About Survodutide in the lab

Survodutide is an acylated peptide that activates both the glucagon and GLP-1 receptors. It is in trials for obesity and fatty-liver disease, and research focuses on how much glucagon-receptor activity adds to GLP-1 effects.

Proposed mechanism

GLP-1 receptor activity affects satiety and insulin secretion; glucagon receptor activity increases hepatic fat oxidation and energy expenditure in models.

Structure note

Peptide with fatty acid acylation (29 amino acids).

Typical research themes

  • Glucagon/GLP-1 co-agonism
  • Hepatic steatosis models
  • Energy expenditure

Regulatory note

This is an investigational compound with no UK marketing authorisation. Research-grade material is not for human or veterinary use.

This profile is a short, general summary of publicly discussed science. It is not exhaustive, not peer-reviewed by PeptideCompare, and is not medical advice. PeptideCompare provides no dosing, protocol or usage guidance — nothing here is for human or veterinary use.

More ways to compare

← Back to catalogue